Literature DB >> 18998832

Using electronic health records to collect patient-specific performance measures and outcomes.

Anil Jain1, Stephen Hayden.   

Abstract

It is clear that performance measurement and quality outcomes are increasingly linked to reimbursement as is EHR adoption. We discuss the role of the secondary use of EHR data in the effort to make measuring and reporting of patient-specific processes and outcomes more efficient. Governance issues, workflow consistently and technical challenges remain obstacles as institutions that have implement EHRs try to obtain high quality data for quality initiatives. Through an interactive workshop, we will explore the role of a multi-disciplinary group at our institution in leveraging our EHR-based clinical data repository to design and implement algorithms for rapidly deriving, validating and delivering patient-specific performance measures and outcomes related to quality improvement projects. Our measures are based on widely-accepted national guidelines. Finally, we will focus on overcoming governance and clinical workflow challenges, extending investments already made in the health IT infrastructure and developing a team to manage the complexity of secondary use of EHR data to measure and impact on quality.

Entities:  

Mesh:

Year:  2008        PMID: 18998832

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  2 in total

1.  Natural language processing accurately categorizes findings from colonoscopy and pathology reports.

Authors:  Timothy D Imler; Justin Morea; Charles Kahi; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-11       Impact factor: 11.382

2.  Sustained improvement in clinical preventive service delivery among independent primary care practices after implementing electronic health record systems.

Authors:  Jason J Wang; Kimberly M Sebek; Colleen M McCullough; Sam J Amirfar; Amanda S Parsons; Jesse Singer; Sarah C Shih
Journal:  Prev Chronic Dis       Date:  2013-08-01       Impact factor: 2.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.